The 72 h crystal violet assay after hypoxic treatment with 75 μM Prima-1 (Fig. 3a) is compatible with reports of Prima-1 anti-tumor activity under hypoxia irrespective of p53 status [8, 11]. The gene discussed is TP53; the disease is neoplasm.